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Abstract
Although several genes that cause monogenie familial cancer syndromes
have been identified, susceptibility to sporadic cancer remains unresolved.
Animal experiments have demonstrated multigenic control of tumor suscep
tibility. Recently, we described four mouse lung cancer susceptibility (Slue)
loci, the main effects of which are masked by their mutual interactions.
Because such interactions can considerably affect the strategies for identifi
cation of cancer susceptibility genes in humans, it is necessary to establish
whether they are common or rare. Here, we report the mapping of 10
additional Sim- loci and show that 13 of the 14 Sim- loci are involved in one
or more interactions, demonstrating that interactions of tumor susceptibility
genes are frequent and that they probably form complex networks.
Introduction
Studies using inbred strains of mice demonstrate a multigenic basis for
many traits, including susceptibility to cancer (1-4). Until recently, the
approaches used to map loci involved in multigenic traits have been
similar to those used to locate genes involved in monogenie traits. To
increase the genetic resolution for mapping QTLs,4 we used RC strains,
a system of mouse inbred strains in which the genetic complexity is
reduced (5). Upon prenatal treatment with the carcinogen ENU, mice of
the strain O20 were more susceptible to lung tumors than were mice of
the strain B10.O20 (6). The O20-congenic-B10.O20/Dem (OcB) series
of RC strains consists of 19homozygous strains, each carrying a different
random subset of â€”¿￿ 12.5% genes from the genome of the common donor
strain B10.O20 on a background of 87.5% genes from the common
background strain O20. In this way, the multigenic difference in lung
tumor susceptibility between the parental strains O20 and B10.O20 was
transformed into mono- oroligogenic differences (5). Because the size of
lung tumors differs significantly between the RC strain OcB-9 and
background strain O20 (7), we previously used (OcB-9 X O20)F2 hy
brids for linkage analysis of lung tumor size. The data were evaluated
using the MQM mapping statistical method, a multilocus method that is
more powerful than single-QTL methods because, in the process of
mapping one QTL, the main and interaction effects of other QTLs are
taken into account (8-10). This analysis revealed four novel interacting
susceptibility loci, Slucl-Sluc4 (11). The individual alÃ-eles of these loci
are not intrinsically susceptible or resistant, but their effect is influenced
by the genotype at the interacting locus. The allelic combinations of SlueI
and Sluc2 corresponding to susceptibility are Slucl020fÃ-}20-Sluc2020/02Â°
and siuel'"a02Â°/l"002u-Sluc2"!aÂ°20""002", whereas the genotypes
Slucl"2W"20-Sluc2ttl0Â°2â„¢"Â»Â°â„¢ and Slucl"'" 02U/tt'Â°02u-Sluc202W02"
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are associated with resistance. A similar interaction was found between
Sluc3 and Sluc4 and between the colon cancer susceptibility loci Scc4 and
SccS (12). Due to these counteracting interactions, the main effect of the
susceptibility loci is masked.
We hypothesized that, if counteracting interactions are a common
characteristic of lung cancer susceptibility, linkage analyses of crosses
between O20 and RC strains with similar phenotypes could also result
in mapping of multiple loci with relatively large effects. Hence, to
map additional Slue loci and to establish whether interactions between
them are common or exceptional, linkage analyses were performed for
both lung tumor size and lung tumor number using three additional
OcB strains. We analyzed F-, crosses between the common back
ground strain O20 and each of the OcB-strains OcB-3, OcB-4, OcB-6,
OcB-9 (tumor number only), and OcB-16, despite the fact that they do
not differ significantly from strain O20 for these traits. We now report
that this approach revealed the mapping of 10 additional Slue loci,
Sluc5-Sluei4. Nine of these loci were found to be involved in one or
more interactions, demonstrating that interactions between lung tumor
susceptibility genes are frequent.
Materials and Methods
Mice and Carcinogen Treatment. The H2 congenie strain B10.O20/Dem
(denoted B10.O20) carries the H2r: haplotype of strain O20/A (denoted O20) on
the C57BL/10 background (N8). The mice used in this study received acidified
drinking water and a standard laboratory diet (Hope Farms. Woerden, the Neth
erlands) ad libitum. They were subjected to a strict light-dark regimen. F2-hybrid
mice were obtained from crosses between the common background strain O20 and
each of the OcB strains OcB-3, OcB-4. OcB-6. OcB-9. and OcB-16. The tumor
number and tumor size (square root-log-transformed, respectively) for these strains
were: O20, 0.78 Â±0.09/3.27 Â±0.14; OcB-3, 0.49 Â±0.11/2.65 Â±0.22: OcB-4.
0.97 Â±0.11/3.02 Â±0.14: OcB-6, 0.63 Â±0.10/2.72 Â±0.18; OcB-9, 0.68 Â±0.11/
2.31 Â± 0.18; and OcB-16.0.74 Â± 0.10/2.78 Â± 0.18. The tumor size of OcB-9 was
significantly different from that of O20. F,-hybrid mice were mated overnight. At
day 18of gestation, pregnant F, mice were treated Â¡.p. with 40 mg/kg body weight
of ENU as described previously (11). The ENU-treated offspring was killed at 16
weeks of age, except for the (O20 X OcB-6)F2 cross, in which one group of mice
was killed at 16 weeks and a second group, denoted (O20 X OcB-6)F2" wk,was
killed at 35 weeks of age. The lungs were fixed in 40% (v/v) ethanol, 5% (v/v)
acetic acid, 4% (v/v) formaldehyde, and 0.41% (m/v) NaCl and embedded in
histowax.
Phenotyping and Genotyping. The whole lungs were sectioned semiserially
(5-fj.m sections at 100-/xm intervals (5-Â¿unsections at 100-fÂ¿mintervals) and
stained with H&E. Lung tumor number and lung tumor size were determined
microscopically as described (11). DNA of F2-hybrid mice was isolated from their
tails and genotyped with simple sequence length polymorphic markers (Mouse
MapPairs; Research Genetics. Huntsville, AL; RÃ©f. 11). Marker positions are
based on Version 3.2 of the mouse genome database (see Appendix). Only limited
sets of markers were used to analyze the (O20 X OcB-6)F2 and (O20 X OcB-
6)F'5 wkcrosses because the numbers of degrees of freedom available, defined by
the sizes of these crosses, were not sufficient to allow the statistical analysis of all
markers necessary to cover the segregating genomic segments and their interac
tions. We choose to use restricted sets of data that included markers in those
genomic regions that overlapped with segregating segments in any of the other
4794MAPPING OF SLUCf TO SLUC14
Table 1 The numbers of F-, mice used in the various crosses anil the likelihood ratio
tesi scores corresponding to the 5% significance thresholds for main effect ami for
interaction effect of each particular linkage analysis
5% significance threshold In'" for:
O20 and:Oc
B -3OcB-3OcB-4OcB-4OcB-6OcB-6OcB-6.
35 wk'OcB-6.
35 wk'OcB-9OcB-9OcB-16OcB-16number
or sizeNumberSizeNumberSizeNumberSizeNumberSizeNumberSizerfNumberSizemice"14113017915791816868220193188169Main interaction effect11.013.613.413.315.923.515.314.312.612.415.619.1Effect11.514.616.013.719.527.920.318.912.413.020.627.8
" Because mice without tumors cannot be included in the linkage analyses of lung tumor
size, more mice are involved in the analyses of lung tumor number than of lung tumor size.
' In. likelihood ratio test scores.
' The cross (O20 X OcB-6)Fv15 wk (see "Materials and Methods").
d See Ref. 11.
crosses (13. 14). as well as the Kras2 marker (7). which is known to be linked to
lung tumor susceptibility (15-18).
Statistical Analysis. Normal distributions were obtained by square root
transformation of lung tumor numbers and '"'log transformation of lung tumor
sizes. The transformed mean tumor sizes per mouse were weighted propor
tionally to the number of tumors per mouse. Outlying values were excluded.
MQM mapping was performed as described previously (11). Tumor number
and tumor size are regressed on the markers in the segregating regions, on sex
of the mice, and on interactions between pairs (marker-marker and marker-
sex). This multilocus model contains parameters for additive and dominance
effects per marker and for additive-by-additive effects per pair. Parameters for
additive-by-dominance, dominance-by-additive, and dominance-by-domi-
nance effects per pair were not be included so that the available degrees of
freedom would not be exceeded. For each cross and for each phenotype (tumor
number and tumor size), the likelihood ratio test scores corresponding to the
5% significance thresholds for main effect and interaction effect on a cross-
specific basis were determined by permutation tests. In each of at least 1000
runs, the original phenotypic data were randomly coupled to the original set of
marker data. Those crosses appearing to reveal significant linkage data were
permutated 2000 times.
Results and Discussion
Most of the genomic segments that segregate in each of the F2
crosses have been identified (13, 14).The list of microsatellite mark
ers used to type these segregating areas can be obtained from the
authors. Because the various crosses involve different numbers of
mice and markers, the likelihood ratio test values that represent the
5% significance threshold for each particular linkage analysis (Table
1) were established by permutation tests. The corrected significant
(P < 0.05) linkage data for lung tumor number and lung tumor size
are listed in Table 2, together with near-significant linkage data
(P < 0.10) that confirm these loci. They include the 10 new lung
cancer susceptibility loci Sluc5-Slucl4. the Kras2 gene/region (7,
15-18), and sex of the mice. The newly mapped Slue loci are located
in regions of the mouse genome in which no lung tumor susceptibility
genes have been mapped before, except for Slue? and Slucl 1. which
are located in the same regions as Par4 and Pas4, respectively
(17, 19).
Nearly all Slue loci were detected as participants in pairwise
interactions, in which the effect of one locus depends on the
genotype of its interacting partner (Table 3. C-H). Significant
main effects were only observed for Krax2 (Table 3A) and SlucI3
(Table 3B). The estimated effects of Slue loci as presented in Table
3 are calculated from the MQM model. When interpreting these
data, one should take into account that the MQM model we used
fitted interactions with additive-by-additive effects only (see "Ma
terials and Methods"). Several of these interactions are completely
counteracting, e.g., the interaction between Sluco and Sluc8: indi
cations of main effects for Sluco and SlucS were not obtained
(Table 3C). Other interactions are partially counteracting, e.g., the
one between SlucS and Slucl2. Although no main effect could be
observed for the Slucl2 locus, the SlucS locus does exhibit a
Table 2 Cross-specific corrected significant (P < 0.05) and near-significant (P < O.IOllinkage data of the Slue loci and their interactions, affecting Inni; nunor muniwr or lung nantir rÃ '
Genomic positionMarker
Chromosome no.SexSexSexSexDIMitISDIMÃ￿136DIMit36D2MÃ￿I56'D2MU56D4MÃ￿H58D6MÃ￿U58D6MU218'Kras2D7Nds4D8Mit35D9Mit2D9MÃ￿12D9MU2D9MÃ￿U2D9MÃ￿112DI
IMil 15'D12Nds2D14MÃŒI120DI8MÃŒ117D19MU9'11122466678999991112141819Distance
from
acromene (cM)88929238386766174725917171755554060132047Interacting withD9MÃŒ112D18MÃŒII7D9MU2D12Nds2D9MÃŒ12D9MÃŒI12D19MÃŒ19D9MÃŒ12D7Nds4D8MU35DIlMitISD4MU158D6MÃŒ1I58D2MU56DIMU36SexSexD1MU36D6MÃŒ1218D1MÃŒII5SexD2MU56F-,
cross between
O20 and:OcB-4Oc
B -4OcB-3OcB-4OcB-6.
35 wk*OcB-4OcB-4OcB-9OcB-4OcB-9OcB-4OcB-9OcB-6OcB-9OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-9OcB-6,
35 wk*OcB-6OcB-4OcB-9Influencing
tumor
size or numberSizeSizeSizeSizeSizeSizeSizeSizeSizeNumberSizeSizeNumberNumberSizeSizeSizeSizeSizeSizeSizeSizeNumberSizeSizeIn"25.8313.8911.5411.2833.7812.3612.2115.3014.8015.2315.6313.4821.1815.2315.6314.8012.3611.2825.8312.2113.4833.7817.5713.8915.30Corrected P0.0040.0470.0980.0990.0120.0720.0740.0240.0390.0290.0320.0410.0120.0290.0320.0390.0720.0990.0040.0740.0410.0120.0300.0470.024S/m- locusSexSlncSSluc2SlucnSlue?SlucJKrau.SlufHStoiciSilicioSlue
IISluc4Sliicl2SluclJSlm-14Slucl
' In. likelihood ratio test score.
'' The cross (O20 X OcB-6)F,35
See Ref. 11.
"k (see "Materials and Methods").
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Table 3 Estimated effects of the Slue tot'i on lung tutnttr niimher und on litng tumor size
The data are presented as deviations from the mean tumor number or mean tumor si/e. indicated by constant c. The transformed means and SEs for the crosses with individual strains (tumor
size and tumor number) were: OcB-3. 3.11 Â±0.69/1.54 Â±0.69; OcB-4. 2.91 Â±0.74/1.77 Â±0.95: OcB-6. 2.92 Â±0.39/1.53 Â±0.78; OcB-9, 2.90 Â±0.52/1.55 Â±0.78; OcB-16.
3.24 Â±0.70/1.60 Â±0.76; OcB-6 (35 weeks), 3.72 Â±0.71/2.53 Â±0.74. The main effects of the interacting Slue loci (C-H) are estimated based on a 1:2:1 ratio of the bb:bu:tm genotypes.
iViico (D4MÃŒII58 region)
I'hho
00erne
SlucSSluc5
(DIMitlS region)
bb
bo00erne
SlucI2Sluc7
(D6MÃŒI158 region)
bb
bo00eme
SlucVSluc2
(D2MÃ￿I56 region)
bb
bo
oo
erne SlucIOSex
Female
Male
erne Slucl 1Sex
Female
Male
eme Sluci 4bb"-0.43
(27)'B.0.37
(24)0.44(15)
0.04 (30)
-0.29(17)
0.05-0.96(4)
0.00(9)
0.96(4)
0.00-0.41
(6)
-0.12(16)
0.26(6)
-0.100.15(6)
0.08(17)
-0.19(9)
0.03-1.00(27)
0.58(16)
-0.210.43
(20)
-0.44 (25)
-0.00bo"A.
Kras2 (Kras2 region) (e17= 1.73)
-0.37 (48)SluclJ
(D14MÃœ120 region) (c = 1.73)0.02
(46)C.
SlucS (D7Nds4 region) (C = 1.31)0.03
(27)
0.01 (47)
0.05 (22)
0.02D.
Slue 12 (D12Nds2 region) (c = 3.74)-0.46
(6)
-0.09(18)
0.28 (7)
-0.09E.
Sluc9 (D8MÃŒ135 region) (c = 3.27)0.09(19)
-0.07 (50)
-0.14(28)
-0.05F.
SlucIO (D9MU2 region) (c = 3.27)-0.18(23)
0.21 (37)
0.39 (29)
0.16G.
5/Hc// (D9MUI2 region) (c = 3.27)-0.22
(38)
-0.18(41)
-0.20H.
SlucI4 (D18MU17 region) (c = 3.27)-0.20(29)
-0.14(36)
-0.17ooc0.43(16)-0.37(21)-0.45(16)
-0.10(32)
0.31 (14)
-0.090.22
(5)
0.00(8)
-0.22(7)
0.000.64(10)
0.03(17)
-0.50(5)
0.05-0.72
(8)
0.12(21)
0.76 (7)
0.070.95(14)
-0.54(21)
0.21-0.48
(30)
0.48(17)
0.00enw/
Slui 60.01-0.01
0.03erne
Slut 5-0.42
-0.04
0.33eme
Slue?0.11
-0.06
-0.13erne
Sluc2-0.23
0.16
0.34erne
sex-0.12-0.08eme
sex-0.11
-0.06
" hb. homozygosity for the BIO.O20 alÃ-ele.
' bo, heterozygosity.
' oo. homozygosily for the O20 alÃ-ele.
C, the estimated square root-transformed mean tumor number (A-C) and the estimated ""log-transformed mean tumor si/.e (D-H) from which the individual cells in the tables deviate.
' Numbers in parentheses represent numbers of mice per genotype.
' erne, estimated main effect.
potentially detectable main effect (Table 3D). The multiplicity
of the pairwise interactions suggests the existence of com
plex functional networks of susceptibility loci. However, the anal
ysis of such higher-order interactions would require much larger
crosses.
Some genomic regions segregate in more than one of the F2 crosses
(13, 14). The Sluc2 locus was detected in both the (OcB-9 x O20)F,
cross and the (O20 X OcB-4)F2 cross, and the SlucS locus was
indicated in the (O20 X OcB-6)F235 wk cross as well as in the
(O20 X OcB-4)F2 cross (Table 2). However, the Slue loci were not
always detected in all crosses where they were expected to segregate.
It is possible that, due to interactions, a Slue gene can be mapped in
one genetic background but not in another because of different gen
otypes at interacting loci. Alternatively, insufficient genetic resolution
of a particular cross, false-positive linkage data (20), or incomplete
knowledge about the genetic constitution of the RC strains, despite the
fact that they are well characterized (13, 14), may also account for the
failure to detect a locus. In some crosses, we did not find any
significant linkage at all. Nevertheless, the highest likelihood ratios
that were obtained corresponded to regions where Slue loci were
identified in other crosses, e.g., the lung tumor size in the F-, crosses
between the strain O20 and the strains OcB-3 and OcB-6 is likely to
be affected by the Slucl region and the Slucl2 region, respectively
(data not shown).
Our data show that lung cancer susceptibility genes are
frequently involved in one or more interlocus interactions. Al
though most of them have potentially large main effects, only a
few of them will exert their single-gene effect in such a way that
they can be detected by single-QTL methods. Incorporation of
interactions into genetic analysis of susceptibility to cancer facil
itates detection of individual loci. Cloning of some susceptibility
loci and uncovering the underlying molecular mechanisms will
result in clues about the interacting partners, contributing to their
identification.
47%MAPPING OF SWC5 TO SLUC1-I
Table AI Reruns of dunor-slrain origin in llie Ocfi strains tested
StrainOcB-3OcB-3OcB-3OcB-3OcB-3OcB-3OcB-3OcB-3OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-4OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OcB-6OeB-6OcB-6OcB-6OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-9OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16OcB-16Chromosome no.17g101314141912246g999101315151515lg112233334456121314141619224666777gg10H16lg1919191912444477gg10121515151618Maximal
segregating areas:
bordering markersCentromere-D
1 Mit5Centromere-D7Mit25Centromere-D8Mitl25Centromere-DIOMil31D13MÃŒ1I65-D13MÃŒ1I3Centromere-D
1 4Mil7Centromere-D
1 4Mit7D19Mit63-telomereDlMit227-DlMit357prox-D2Mit295D2Mit7-D2Mitl28D4Mit2-D4Mil28D6Mitl-DftMiH22D8Mitl5-D8Mit56D9Mit42-D9Mit45D9Mit4-D9Mil6D9Mit31-D9Mitl5DIOMit49-D10Mit31D13Mit53-telomereCentromere-D
15Mil 17 1Centromere-D
1i Mit 17 1Centromere-DI5Miti71Centromere-DlÃ-MitmCentromere-D
I8MÃ￿135DlMit5-DlNds2DlMÂ¡t227-DlMit357Centromere-D2Mit295D2Mit30-telomereCentromere-D3Mit49D3Mit49-D3Mit28D3MitlO-D3Mitl6D3Mitl60-D3Mitl8D4Mit2-D4Mit31D4Mit66-D4Mit42D5Mitl88-telomereD6Mit59-tclomereD
12Mit 144-ielomereD13Mitl39-D13MitllD14Mitl26-D14Mit6D14Nkil-D14Mitl36Centromere-D
16Mit 1 2DI9MÃ￿163-DI9MH7D2Mit5-D2Mit35D2Mil5-D2Mit35D4Mil37-D4Mit42D6Mit21-D6Mil29D6Mit29-D6MitlOD6Mit44-D6Mitl3D7MÃ￿I176-D7MÃ￿166D7Mit66-telomereD7Mit66-telomereCcntromere-DgMil
1 29Centromere-DSMit
1 29DIÃœMit68-D10Mit25DllMit23-DllMit31Centromere-D
16MÃ￿1 10 1D18Mit21-DI8Mit55D19Mit32-telomereD19Mit32-telomereD19Mit32-telomereDI9Mit32-telomereD
1 Mit403-telomereD2Mit53-telomereCentromere-D4Mit55D4Mitl64-D4Mit54D4Mitl64-D4Mit54D4Mit60-telomereCentromere-D7Mit25D7MÃ￿153-D7MU12Centromcre-D8Mil65D8MÃ￿181-D8MU47D10Mitl2-telomereD12Mit6-telomereCentromere-D
15MÃ￿16D15Mitl7-D15Mit29D15Mit29-D15Mitl7lD16MU5-DI6MÃ￿171DISMitS-telomereMaximal
(cMl0-330-160-170-3630-350-440-4424-5682-1000-2028-477-493-2945-73g-2429-3135-612-3662-750-550-550-550-550-2433-5982-1000-2069-1200-4141-4350-6670-767-5169-8164-9g67-7758-6132^405-2943-600-2824-515^455-1557-8135-3737-4951-6327-5858-7458-740-310-3152-6828-400-176-250-560-560-560-56100-11484-1200-2029-6729-0782-840-1652-660-2341-5356-8045-610-2232-4343-5538-6947-59Minimal (cM)0-260-40-110-932-320-430^t341-5687-920-532-4311-166-758-679-1729-2935-564-975-750-220-2232^1932^190-2041-5987-920-573-1200^4045^4553-6472-7611-5069-7172-9872-7758-6133-4010-2044-540-2341-5120-3820-3858-7135-3539-4661-6336-5264-7464-740-230-2356-6733-400-417-247-567-567-567-56102-114107-1200-2043-4958-6483-840-1558-650-1745^4558-8048-610-1340-4049^(954-5450-59Genotyped with markerDIMU170D7MÃ￿I57D8MU3DIOMitSID13MÃ￿II39D14MÃ￿U20D14Mit28D19MÃŒI3D1MÃ￿I36D2MÃ￿15D2MÃ￿I56D4MÃ￿I4D6MÃ￿H58D8MÃ￿I35D9MÃ￿I2D9MÃ￿I12D10MÃ￿128D13MÃ￿178D15MÃ￿113"DISMttS*D15Nds3"D15MÃ￿196DI8MÃ￿H7DIMÃ￿116/I5D2MÃ￿I51'D2MÃ￿1200D4MÃ￿I23Kras2D12Nds2D14MÃ￿1I20DI9MÃ￿13D2MÃ￿I7''D2MÃ￿156D4MÃœI58D6MÃ￿I211'D6MU2I8D7MÃ￿132D7MÃ￿I105''D7Nds4D8MÃ￿13D8MÃ￿1651'DIOMÃ￿1122DIIMillSDI6MÃ￿19DI8MÃ￿117DI9MÃ￿I61DI9MÃ￿I631'D19MU9D19MÃ￿I33''D1MÃ￿1221D2MÃ￿1200D4MÃ™5D4MÃ￿170D7MÃ￿155D7Mitl05D8MÃ￿13D8MÃ￿115D10MÃœI22DI2Nds2DI5MÃ￿1I3DI5MÃ￿196D16MÃ￿H9DI8Mit7Position (cM)204III9321329509253812659175547572233492(187/885111714746013502838673561466472Id23614042092447531(121(17186215641(14561607495450
" Included in the analysis of lung tumor number, excluded from the analysis of lung tumor size due to limited availability of degrees of freedom.
'' Included in the analysis of lung tumor size, excluded from the analysis of tumor number.
' Excluded from the analyses of the (O20 X OcB-6)Fv " w cross due to limited availability of degrees of freedom.
'' The main effect was included in the analysis, the interaction effect was excluded due to limited availability of degrees of freedom.
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Appendix
Regions of the mouse genome known to segregate in the F2 crosses between
background strain O20 and each of the RC strains OcB-3, OcB-4, OcB-6.
OcB-9. and OcB-16. and the markers used to genotype these crosses are shown
(Table A1 ). The bordering markers of the segregating areas indicate the
maximal possible segregating regions. The areas between maximal and mini
mal segregating regions are the sites where recombination took place. Marker
positions are based on Version 3.2 of the mouse genome database (http://www.
informatics.jax.org/mgd.html).
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